LSL Pharma Group Secures $1.5 Million in Non-Brokered Private Placement

Jun 27, 2024

Contract Type

agreement

BouchervilleManufacturingBiotechnologyHealth CarePharmaceuticalDietary Supplements

Description

LSL Pharma Group Inc. has successfully met the closing conditions of a non-brokered private placement, raising $1.5 million from the issuance of 3,727,000 units at $0.40 per unit. The proceeds will be used to expand production capacity and for general working capital purposes.

Company Information

Company

LSL Pharma Group

Location

Boucherville, Quebec, Canada

About

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. . Leveraging its technical expertise, certified facilities, and experienced team, LSL Pharma delivers high-quality solutions that meet the highest industry standards. The companies that are part of the LSL Pharma Group are Steri-Med Pharma Inc., Laboratoire LSL Inc., Virage Santé Inc., Dermolab Pharma Ltd. and Laboratoire Du-Var Inc.